Pfizer-BioNTech COVID-19 vaccine approved for children ages 12 to 15
By: Alyssa Wilson
The Food and Drug Administration has approved the Pfizer-BioNTech COVID-19 vaccine to be used in children as young as 12 on an emergency use basis.
Acting FDA Commissioner Dr. Janet Woodwock said the decision by the organization can get the United States closer to a return to normal and that they took the review seriously, CNBC reported.
A clinical trial involving more than 2,000 12-to-15-year-olds revealed that the vaccine was well tolerated. It had an efficacy rate of 100% within the age group.
On Wednesday, the CDC endorsed the safety and effectiveness of the Pfizer-BioNTech vaccine for the age group.
Pfizer and BioNTech also began testing the vaccine on children between the ages of 6 months and 11 years old.